Provider review
Zeuss review
No subscription: buy a 60-day supply of an unnamed GLP-1 when you want one.
Reviewed by Lena OrtizMetabolic Health Editor
Price updated October 2026
We may earn a commission at no extra cost to you. Affiliate partners are listed first on our rankings. How we’re funded.
$250 or $398 per 60-day supply, no subscription
Visit ZeussThe price covers the review, medication and cold shipping; neither product names its drug.
Price as published
Zeuss
$250 or $398 per 60-day supply, no subscription
FDA warning letter · Zeuss · February 2026 · addressed to Zeuss LLC dba Zeuss. Details in our review.
- Vs median
- Not comparable — no per-month rate is published — the verified string carries no monthly figure
- Market
- $59–$1,300/mo across 299 of 548
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Compounded, 503A or 503B pharmacies, not named
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
In one paragraph
The verdict
Zeuss is built around one idea: no subscription and no automatic refill. You buy a 60-day supply, and when it runs out you order the next one yourself, which suits anyone wary of renewal traps. The price includes the provider review, the medication and cold-chain shipping. The monthly figures on the page are simply the 60-day price halved, so you pay for two months at a time. The bigger drawback is that the two products are named only by receptor, GLP-1 and GIP/GLP-1, without saying which drug either is. Zeuss pitches the format for maintenance dosing, but there is no low-dose product. The terms name a compounding pharmacy and let you ask for a different one. Fees are spelled out: cancel before the telehealth visit for a full refund, but a consultation fee is kept after it and a missed visit costs extra, and nothing can be canceled once the pharmacy has started.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Who it suits, and who it does not
A good fit if
- You want no subscription and no automatic refills
- You are already on a stable dose and reorder on your own schedule
- You want the option to choose another compounding pharmacy
Look elsewhere if
- You want to know which drug you are buying before you start
- You would rather pay one month at a time
- You want a dedicated low-dose product
What it actually costs
Price as published
$250 or $398 per 60-day supply, no subscription
- Vs median
- Not comparable — no per-month rate is published — the verified string carries no monthly figure
- Market
- $59–$1,300/mo is the full published spread on this site
- Structure
- Standard plan, self-directed low dose
No low-dose product of its own. Starting low means asking for a smaller amount inside a standard plan, at the standard plan's price.
235 of the 548 programs here price a small dose this way. Two compounded products named only by receptor, each sold as a sixty-day supply with no subscription. The page pitches them for maintenance dosing, but no low-dose product exists and neither product names its drug.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
What is included
- Consult
- Included in the price
- Dietitian
- Not confirmed
- Labs
- Not required
- Pricing
- Check plan terms
What it does well
- There is no subscription: you order each 60-day supply only when you want one
- The price covers the provider review, medication and cold-chain shipping
- The terms name a pharmacy and let you request a different one
- A full refund if you cancel before the appointment or are found ineligible
Pharmacy, labs and oversight
Zeuss says it uses 503A or 503B pharmacies, but does not say which one. No bloodwork is required before you start. A clinician review is included in the price.
Transparency check
0 of 4 published openly
What Zeuss publishes about itself, read from its own pages when we verified them — not estimated, and not a score.
- Pharmacy named and regulatedSays it uses 503A or 503B pharmacies, but does not say which one.
- Not published
- A price you can read before intakeThe figure appears only after an intake quiz, so it cannot be compared before signing up.
- Not published
- What a higher dose costsPriced by dose, plan or tier, and the higher rungs are not published — the advertised figure does not tell you what a larger dose costs.
- Not published
- FDA warning letter on fileOne is on file. The disclosure and the FDA's own database are directly below.
- On file
FDA warning letter
The U.S. Food and Drug Administration issued a warning letter to Zeuss in February 2026. It is addressed to Zeuss LLC dba Zeuss — search that name, not ours, to find it. We are not summarizing what it says — read it at the source. This does not change how Zeuss is listed here or whether we are paid for a click to it, and we would rather you knew both of those things at once.
How the program works
Zeuss is a Florida-based telehealth platform for weight loss, skin, hair and hormone care. Its weight-loss offer is two compounded products named only by receptor, GLP-1 and GIP/GLP-1, each sold as a 60-day supply with no subscription and no automatic refill; you reorder your next vial when you want it. The page pitches this as suiting maintenance dosing. A licensed provider reviews your intake, may hold a telehealth appointment, and sends the prescription to a partner 503A or 503B compounding pharmacy; the terms name Strive Pharmacy and say you may ask to use another compounding pharmacy instead. Orders can be canceled for a full refund before the telehealth appointment and are refunded if you are ruled ineligible. Once the pharmacy processes a prescription it cannot be canceled or refunded. No microdose product is sold.
The honest cons
Neither product names its drug: they are called GLP-1 and GIP/GLP-1
- The monthly figures are a 60-day purchase halved; you pay for two months at once
- A $60 consultation fee is kept if you cancel after the visit, and a missed visit costs $30
- Nothing can be canceled once the pharmacy has processed it
- No low-dose product is offered
- Compounded GLP-1s are not FDA-approved, and intentional microdosing is off-label and unproven
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
How it compares
Zeuss is one of 548 low-dose GLP-1 programs compared on this site, and 299 of them publish a monthly rate you can read before signing up. The full list puts every published price in one place, with the companies that pay us listed first — something we state there, on the page it applies to.
Also consider
Two more programs that price a small dose the way Zeuss does. Both are partners: we may earn a commission if you start care through these links.
Partner
Sprout Health
$149 sema · $199 tirz
Standard plan, self-directed low dose
FDA warning letter · Sprout Health · September 2025 · addressed to Sprout Health Partners LLC dba Sprout Health. Details in our review.
Partner
Bodybuilding Health+
$179/mo sema · $209/mo tirz
Standard plan, self-directed low dose
Where this sits
#417 of 548
Ordered with the companies that pay us first, and Zeuss is not one of them. A disclosed partition, not a score.
Compare all 548 providers →Read this before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
- Is compounded GLP-1 safe?
- Low dose vs full dose
- What the evidence actually shows
- The true annual cost of a plan
- Vial waste calculator
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
The closest alternative
HealthRX
$190/mo sema · $239/mo tirz (monthly plan)
- Vs median
- $15/mo above the $175 median
- Market
- $59–$1,300/mo across 299 of 548
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
Read the HealthRX review →Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.